Dass-167 【500+ RECENT】

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a profound impact on global health and economies. As the virus continues to spread and evolve, the need for effective treatments and vaccines has become increasingly urgent. In recent months, researchers have made significant progress in identifying potential therapeutic targets and developing novel compounds to combat the virus. One such compound is the DASS-167, a potent inhibitor of SARS-CoV-2 that has shown great promise in preclinical studies.

Typically, these assessments are structured into several subscales: DASS-167